Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CRISPR
CRISPR
The continuing CRISPR patent saga
Endpoints
Thu, 04/8/21 - 10:27 am
gene editing
CRISPR
patents
Intellia announced a new tool for gene editing. Academics said they rewrote history
Endpoints
Tue, 03/30/21 - 10:16 pm
CRISPR
gene editing
Intellia Therapeutics
Caribou Biosciences is Armoring Cells to Fight Disease Through CRISPR
BioSpace
Mon, 03/29/21 - 11:07 pm
Caribou Biosciences
CRISPR
In race for in vivo sickle cell cure, Intellia unveils (very) early proof-of-concept
Endpoints
Thu, 03/11/21 - 10:35 am
Intellia
CRISPR
sickle cell disease
Jennifer Doudna’s Second Act: COVID-19 and Beyond
BioSpace
Wed, 03/10/21 - 11:16 am
Jennifer Doudna
CRISPR
COVID-19
pandemic
Doudna-founded biotech Caribou raises fresh funds to fuel gene editing pipeline
BioPharma Dive
Wed, 03/3/21 - 11:00 am
Caribou Biosciences
Jennifer Doudna
CRISPR
gene editing
Coming of Phage: Clinical trial underscores safety of technology battling E. coli triggered UTIs
Biopharma Reporter
Thu, 02/25/21 - 10:36 am
bacteriophage
phage
CRISPR
Locus Biosciences
precision medicine
UTIs
clinical trials
Ensoma debuts with $70M, Takeda deal to pursue off-the-shelf genomic medicines
Fierce Biotech
Thu, 02/11/21 - 10:37 am
Ensoma
Takeda
CRISPR
gene editing
genomic medicine
After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact
Fierce Biotech
Wed, 02/10/21 - 10:27 am
AbbVie
Editas Medicine
CRISPR
Caribou Biosciences
gene editing
Tracking cancer metastasis with CRISPR opens new areas for drug development
Fierce Biotech
Sat, 01/23/21 - 11:41 pm
cancer
metastasis
CRISPR
R&D
Where Will CRISPR Therapeutics Be in 10 Years?
Motley Fool
Tue, 12/15/20 - 10:44 am
CRISPR
CRISPR Therapeutics
1st Patients To Get CRISPR Gene-Editing Treatment Continue To Thrive
NPR
Tue, 12/15/20 - 10:32 am
CRISPR
gene editing
sickle cell disease
Bayer powers gene-editing startup Metagenomi to $65M A round
Fierce Biotech
Thu, 11/12/20 - 10:55 am
Metagenomi
Bayer
CRISPR
gene therapy
gene editing
Intellia, beginning treatment in CRISPR study, secures Gates Foundation backing
BioPharma Dive
Wed, 11/11/20 - 11:03 pm
Intellia Therapeutics
CRISPR
gene editing
Gates Foundation
Locus Biosciences bags up to $12.1M for CRISPR antibacterial; Old Vertex drug heads to PhIII for dementia
Endpoints
Tue, 11/10/20 - 11:02 am
Locus Biosciences
CARB-X
CRISPR
rUTIs
UTIs
bacteriophage
EIP Pharma
Vertex Pharmaceuticals
dementia
clinical trials
CRISPR and Vertex Release Additional Data for Blood Disease Treatment
Motley Fool
Wed, 11/4/20 - 10:50 pm
CRISPR Therapeutics
CRISPR
Vertex Pharmaceuticals
CTX001
beta thalassemia
sickle cell disease
Despite Recent Bad News, Here's Why CRISPR Is Primed to Explode
Motley Fool
Mon, 11/2/20 - 10:20 am
CRISPR
CRISPR Therapeutics
clinical trials
CRISPR stock slides as CAR-T death overshadows signs of efficacy
Fierce Biotech
Wed, 10/21/20 - 10:54 am
CRISPR
CRISPR Therapeutics
CAR-T
patient deaths
Intellia Aims Big with CRISPR Therapy to Cure ATTR
BioSpace
Tue, 10/20/20 - 10:44 am
Intellia Therapeutics
CRISPR
hereditary ATTR amyloidosis
NTLA-2001
BARDA and Locus in tie-up to tackle UTIs with phages
Biopharma Reporter
Mon, 10/12/20 - 10:30 am
Locus Biosciences
BARDA
LBP-EC01
CRISPR
bacteriophage
UTIs
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »